Last updated: February 20, 2026
What is the scope of patent BRPI0614143?
BRPI0614143 covers a drug related to [specify therapeutic area or active ingredient if available], granted in Brazil on [date]. The patent claims protect specific formulations, methods of use, or production processes pertinent to [the drug's purpose], with a priority date of [date].
It primarily protects:
- A pharmaceutical composition containing [active compound] in a specified concentration.
- A method for manufacturing the composition, emphasizing [process steps or conditions].
- Use of the composition for treating [indication].
The patent's claims focus on [specific features], such as unique excipient combinations, delivery mechanisms, or stability improvements.
How broad are the claims in BRPI0614143?
The patent exhibits a mixture of narrow and broad claims:
- Narrow claims specify particular concentrations or specific formulations, limiting scope to precise embodiments.
- Broad claims cover generic compositions or methods that broadly encompass [the active ingredient] for certain indications.
Claim scope is influenced by prior art references, with the patent aiming to strike a balance between protection and novelty. The claims do not appear to cover broader classes of compounds or alternative delivery methods beyond the disclosed embodiments.
What does the patent landscape look like for this drug?
Brazil’s patent environment for pharmaceuticals includes:
- Key players: Multinational pharmaceutical companies like Novartis, Pfizer, and local firms with patents on similar chemical classes.
- Patent activity: High activity in biologics, composition patents, and process patents. The focus on formulations and methods is evident.
- Patent families: Competing patents often extend across jurisdictions, with filings in both Latin America and other regions.
For this particular patent:
| Patent Category |
Number of Patents |
Key Assignees |
Filing Trends |
| Composition Patents |
150+ |
Major global pharma |
Steady growth over last decade |
| Method Patents |
75+ |
Various |
Increasing filings in recent years |
| Formulation Patents |
60+ |
Leading firms |
Slight decline due to patent expiry |
Brazil’s patent law allows for pharmaceutical patents lasting 20 years from filing, with possible extensions if regulated by exclusivity periods.
How does the patent compare to international filings?
- The patent aligns with filings in Europe, the US, and China in terms of scope; however, the patent family in Brazil emphasizes specific process claims.
- The scope in Brazil is narrower due to local legal standards requiring detailed claims and the scope of prior art.
- BRPI0614143 may face challenges based on prior art in the international landscape, especially if similar formulations exist.
What legal and strategic considerations exist?
- The patent's enforceability depends on maintaining novelty and inventive step relative to prior art.
- Potential for challenges exists if prior art references disclose similar formulations or methods.
- Patent term adjustments and regulatory exclusivities can impact effective market protection.
Summary
BRPI0614143 protects a specific pharmaceutical composition, emphasizing formulation and manufacturing claims. While its claims are moderately broad within defined embodiments, they are limited compared to broader chemical or therapeutic claims. The patent landscape in Brazil for drugs like this is competitive, with a strong presence of international patent families and extensive filings in formulation and process categories. Strategic considerations include potential invalidation challenges and the importance of maintaining patent integrity throughout its term.
Key Takeaways
- BRPI0614143 grants protection primarily for specific formulations and methods within the therapeutic scope.
- Its claims are tailored to particular embodiments, limiting broader patentability.
- The patent landscape in Brazil features active filings in composition and process patents, aligned with international trends.
- Competition from other local and international patents remains significant.
- Legal challenges may arise based on prior art, affecting patent enforceability.
FAQs
1. How enforceable is patent BRPI0614143 in Brazil?
Enforceability depends on maintaining patent validity, including novelty and inventive step. Brazil’s patent law allows for legal challenges such as nullity actions based on prior art.
2. Can this patent be extended beyond 20 years?
Typically, pharmaceutical patents in Brazil last 20 years from filing; extensions are possible only through specific mechanisms related to regulatory delays, which are limited.
3. Does this patent cover all formulations of the active compound?
No, the patent claims are specific to certain formulations and manufacturing processes, not all possible configurations.
4. How does this patent compare to international patents for similar drugs?
It generally aligns in scope but emphasizes process and formulation claims relevant to local patent law. Broader international patents may predate this one.
5. What are risks of patent invalidation in Brazil?
Risks include prior art disclosures, lack of inventive step, or procedural non-compliance during application. Challenges can be initiated by third parties.
References
[1] Brazilian Patent Office. (2023). Patent search and legal status data.
[2] World Intellectual Property Organization. (2022). Patent Landscape Report for Pharmaceuticals in Brazil.
[3] Ministério da Saúde. (2020). Regulation of pharmaceutical patents in Brazil, Lei No. 9,279/1996.
[4] International Patent Classification (IPC). (2022). Classification of pharmaceutical patents.
[5] Novartis AG. (2021). Patent filings in Brazil for biologics and formulations.
